AltruBio is developing first-in-class immune-modulators to target diseases of the immune system. Its world-class global team brings a breadth of expertise in immunology and drug development to bring their biologic treatments to patients.
AltruBio’s senior management is built on a team of individuals possessing strong academic knowledge, high-level managerial experience and scientific expertise in a range of fields including life science, pharmacology, healthcare and immunology.
b2/20220119085816jfyqzzCp68.png)
Judy Chou, Ph.D.
President and Chief Executive Officer
b2/202201190858155rte5dGc45.png)
Jeroen Grasman
Chief Financial Officer
b2/20220119085815okyddzEyf6.png)
Jesse W. Hall, MD
Chief Medical Officer
b2/20220119085814hm9togcUw2.png)
Shih-Yao Lin, MD., Ph.D.
Vice President of Research
b2/20220119085815fmusyhuTo3.png)
Gene Lee, Ph.D.
Vice President of Technical Development
b2/20220119085816lalxioIK49.png)
Leewen Lin, Ph.D., LL.M.
Vice President of Legal Affairs
b2/20220119085817euwtdxDul13.png)
Simona Reed, Ph.D.
Vice President of Clinical Operations
b2/20220119085815uy99ygMIe7.png)
Joseph S. McCracken, DVM, MS
Head of Business Development
b2/20220119085816pqgb3iAiV10.png)
Patrick Y. Yang, Ph.D.
Chairman of the Board
Judy Chou, Ph.D.
President and Chief Executive Officer
b2/20220119085816bxkhawFF612.png)
Sean P. Bohen, M.D., Ph.D.
b2/2022011909321298gqakCig1.png)
John Doyle
b2/20220119085817xweeoaFzO14.png)
Stephen G. Juelsgaard, D.V.M., J.D.
b2/202201190858149yafueQhS4.png)
Gur Roshwalb, M.D.
b2/20220119085814wycs59cLB1.png)
Corsee Sanders, Ph.D.
David T. Rubin, MD, AGAF, FACG, FASGE, FACP
Joseph B. Kirsner Professor of Medicine